These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18313303)

  • 1. A novel synthesis and pharmacological evaluation of a potential dopamine D1/D2 agonist: 1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinoline-6,7-diol.
    Liu D; Dijkstra D; de Vries JB; Wikström HV
    Bioorg Med Chem; 2008 Mar; 16(6):3438-44. PubMed ID: 18313303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extremely potent orally active benzo[g]quinoline analogue of the dopaminergic prodrug: 1-propyl-trans-2,3,4,4a,5,7,8,9,10,10a-decahydro-1H-benzo-[g]quinolin-6-one [corrected].
    Liu D; Wikström HV; Dijkstra D; de Vries JB; Venhuis BJ
    J Med Chem; 2006 Feb; 49(4):1494-8. PubMed ID: 16480286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological characterization of novel hybrid 7-[[2-(4-phenyl-piperazin-1-yl)-ethyl]-propyl-amino]-5,6,7,8-tetrahydro-naphthalen-2-ol and their heterocyclic bioisosteric analogues for dopamine D2 and D3 receptors.
    Dutta AK; Venkataraman SK; Fei XS; Kolhatkar R; Zhang S; Reith ME
    Bioorg Med Chem; 2004 Aug; 12(16):4361-73. PubMed ID: 15265488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and dopaminergic properties of benzo-fused analogues of quinpirole and quinelorane.
    Doll MK; Nichols DE; Kilts JD; Prioleau C; Lawler CP; Lewis MM; Mailman RB
    J Med Chem; 1999 Mar; 42(5):935-40. PubMed ID: 10072690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of dopamine receptor subtypes by comparative structure-activity relationships: dopaminomimetic activities and solid state conformation of monohydroxy-1,2,3,4,4a,5,10,10a-octahydrobenz[g]quinolines and its implications for a rotamer-based dopamine receptor model.
    Seiler MP; Markstein R; Walkinshaw MD; Boelsterli JJ
    Mol Pharmacol; 1989 May; 35(5):643-51. PubMed ID: 2566903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-(Iodopropenyl)-octahydrobenzo[f]- and -[g]quinolines: synthesis and adrenergic and dopaminergic activity studies.
    Tagmatarchis N; Thermos K; Katerinopoulos HE
    J Med Chem; 1998 Oct; 41(21):4165-70. PubMed ID: 9767652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indoloquinolizidine-peptide hybrids as multiple agonists for D1 and D2 dopamine receptors.
    Vendrell M; Soriano A; Casadó V; Díaz JL; Lavilla R; Canela EI; Lluís C; Franco R; Albericio F; Royo M
    ChemMedChem; 2009 Sep; 4(9):1514-22. PubMed ID: 19557804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacological evaluation of thiazole and isothiazole derived apomorphines.
    Sipos A; Mueller FK; Lehmann J; Berényi S; Antus S
    Arch Pharm (Weinheim); 2009 Oct; 342(10):557-68. PubMed ID: 19714675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of human dopamine receptors agonists from Chinese herbs.
    Zhang YL; Zhang HQ; Liu XY; Hua SN; Zhou LB; Yu J; Tan XH
    Acta Pharmacol Sin; 2007 Jan; 28(1):132-9. PubMed ID: 17184593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and structure-activity relationship studies of hexahydropyrazinoquinolines as a novel class of potent and selective dopamine receptor 3 (D3) ligands.
    Ji M; Chen J; Ding K; Wu X; Varady J; Levant B; Wang S
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1701-5. PubMed ID: 15745825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-substituted 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines and 3-phenylpiperidines: effects on central dopamine and sigma receptors.
    Wikström H; Andersson B; Elebring T; Svensson K; Carlsson A; Largent B
    J Med Chem; 1987 Dec; 30(12):2169-74. PubMed ID: 2824773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzo[g]quinolines. I. Synthesis and pharmacological evaluation of cis- and trans-1-alkyl-5,5-dimethyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-7-ol. A new class of narcotic antagonists.
    Michne WF; Albertson NF
    J Med Chem; 1969 May; 12(3):402-5. PubMed ID: 5788153
    [No Abstract]   [Full Text] [Related]  

  • 13. New 2-thioether-substituted apomorphines as potent and selective dopamine D₂ receptor agonists.
    Reinart R; Gyulai Z; Berényi S; Antus S; Vonk A; Rinken A; Sipos A
    Eur J Med Chem; 2011 Jul; 46(7):2992-9. PubMed ID: 21550699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monophenolic octahydrobenzo[f]quinolines: central dopamine- and serotonin-receptor stimulating activity.
    Wikström H; Sanchez D; Lindberg P; Arvidsson LE; Hacksell U; Johansson A; Nilsson JL; Hjorth S; Carlsson A
    J Med Chem; 1982 Aug; 25(8):925-31. PubMed ID: 6811743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Substituted-2-alkyl- and 2-arylnorapomorphines: novel, highly active D2 agonists.
    Herm L; Berényi S; Vonk A; Rinken A; Sipos A
    Bioorg Med Chem; 2009 Jul; 17(13):4756-62. PubMed ID: 19454369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and functional activity of (2-aryl-1-piperazinyl)-N-(3-methylphenyl)acetamides: selective dopamine D4 receptor agonists.
    Matulenko MA; Hakeem AA; Kolasa T; Nakane M; Terranova MA; Uchic ME; Miller LN; Chang R; Donnelly-Roberts DL; Namovic MT; Moreland RB; Brioni JD; Stewart AO
    Bioorg Med Chem; 2004 Jul; 12(13):3471-83. PubMed ID: 15186832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacological evaluation of substituted naphth[1,2,3-de]isoquinolines (dinapsoline analogues) as D1 and D2 dopamine receptor ligands.
    Qandil AM; Lewis MM; Jassen A; Leonard SK; Mailman RB; Nichols DE
    Bioorg Med Chem; 2003 Apr; 11(7):1451-64. PubMed ID: 12628671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders.
    Zhang A; Neumeyer JL; Baldessarini RJ
    Chem Rev; 2007 Jan; 107(1):274-302. PubMed ID: 17212477
    [No Abstract]   [Full Text] [Related]  

  • 19. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
    Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M
    Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines: structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonists.
    Wikström H; Andersson B; Sanchez D; Lindberg P; Arvidsson LE; Johansson AM; Nilsson JL; Svensson K; Hjorth S; Carlsson A
    J Med Chem; 1985 Feb; 28(2):215-25. PubMed ID: 3968686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.